[1. Dall’Era M, Wofsy D. Clinical Manifestations of Systemic Lupus Erythematosus. Firestein GS, Budd RC, Gabriel SE, MacInnes IB, O’Dell JR, eds. Kelley and Firestein’s Textbook of Rheumatology. 10th ed. Philadelphia, Pa: Elsevier Saunders; 2017. 1345-67.10.1016/B978-0-323-31696-5.00080-2]Search in Google Scholar
[2. Daniel J Wallace, MD, Dafna D Gladman, MD, FRCPC, Clinical manifestations and diagnosis of systemic lupus erythematosus in adults, https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-systemic-lupus-erythematosus-in-adults?search=lupus%20erythematosus&topicRef=4675&source=see_link]Search in Google Scholar
[3. Botou A, Bangeas A, Alexiou I et al. Acroosteolysis. Clin Rheumatol 2017;36:914]Search in Google Scholar
[4. L. Guillevin, Vasculopathy and pulmonary arterial hypertension, Rheumatology, Volume 48, Issue suppl_3, 1 June 2009, Pages iii54–iii57, https://doi.org/10.1093/rheumatology/ken48410.1093/rheumatology/ken48419487226]Search in Google Scholar
[5. A.K.ROBSON,* S.M.BURGEt & P.R.MILLARDS, Nasal mucosal involvement in lupus erythematosus. Clin. Otolaryngol. 1992, 17, 341-34310.1111/j.1365-2273.1992.tb01009.x1526055]Search in Google Scholar
[6. Yayoi Nagai, Akira Shimizu, Mariko Suto, Setsuko Tanaka, Masahito Yasuda, Osamu Tago, Michiko Hasegawa and Osamu Ishika, Digital Gangrene in Systemic Lupus Erythematosus. Acta Derm Venereol 2009; 89: 398–401]Search in Google Scholar
[7. Paul F Dellaripa, MD, Sonye K Danoff, MD, PhD, Pulmonary manifestations of systemic lupus erythematosus in adults, https://www.uptodate.com/contents/pulmonary-manifestations-of-systemic-lupuserythematosus-in-adults]Search in Google Scholar
[8. Tselios K, Gladman DD, Urowitz MB. Systemic lupus erythematosus and pulmonary arterial hypertension: links, risks, and management strategies. Open Access Rheumatol. 2016;9:1-9. Published 2016 Dec 20. doi:10.2147/OARRR.S12354910.2147/OARRR.S123549519162328053559]Search in Google Scholar
[9. Alarcon Segovia D, Villareal M. Classification and diagnostic criteria for mixed connective tissue disease. In: Mixed Connective Tissue Disease and Anti-nuclear Antibodies, Kasukawa R, Sharp G (Eds), Elsevier, Amsterdam 1987. p.33.]Search in Google Scholar
[10. Dima A, Jurcut C, Baicus C. The impact of anti-U1-RNP positivity: systemic lupus erythematosus versus mixed connective tissue disease. Rheumatol Int. 2018;38(7):1169-1178. doi:10.1007/s00296-018-4059-410.1007/s00296-018-4059-429796907]Search in Google Scholar
[11. Rahman P, Gladman DD, Urowitz MB. Nasal-septal perforation in systemic lupus erythematosus — time for a closer look. J Rheumatol 1999;26:1854-5.]Search in Google Scholar
[12. Bruno E, Russo S, Nucci R, Alessandrini M, DiGirolamo S. Nasal mucosal involvement in systemic lupus erythematosus: histopathologic and immunopathologic study. Int J Immunopathol Pharmacol 2000;13:39-42.10.1177/03946320000130010612749777]Search in Google Scholar
[13. Guntupalli, L., Patel, K., Faraji, F., & Brunworth, J. D. (2017). Autoimmune-Related Nasal Septum Perforation: A Case Report and Systematic Review. Allergy & Rhinology. https://doi.org/10.2500/ar.2017.8.019110.2500/ar.2017.8.0191538045228381327]Search in Google Scholar
[14. Willkens RF, Roth GJ, Novak A, Walike JW. Perforation of nasal septum in rheumatic diseases. Arthritis Rheum 1976; 19:119.10.1002/art.17801901221252263]Search in Google Scholar
[15. Keane MP, Lynch JP 3rd. Pleuropulmonary manifestations of systemic lupus erythematosus. Thorax 2000; 55:159.10.1136/thorax.55.2.159174567810639536]Search in Google Scholar